Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jonas

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
Kidney International|February 14, 1998
Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation modelS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
The effect of cyclosporine vs FK 506 on glucose metabolismT Steinmueller, T Konrad, S Jonas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)S H K Oertel, E Verschuuren, P Reinke, et al.
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Brain death activates donor organs and is associated with a worse I/R injury after liver transplantationS Weiss, K Kotsch, M Francuski, et al.
Psycho-Oncology|March 16, 2013
Co-morbid mental health conditions in cancer patients at working age--prevalence, risk profiles, and care uptakeS Singer, C Szalai, S Briest, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 14, 2011
Managing chronic myeloid leukemia: a coordinated team care perspectiveStacie Holloway, Katharine Lord, Beverly Bethelmie-Bryan, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
Kidney International|February 14, 1998
Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation modelS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
The effect of cyclosporine vs FK 506 on glucose metabolismT Steinmueller, T Konrad, S Jonas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)S H K Oertel, E Verschuuren, P Reinke, et al.
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Brain death activates donor organs and is associated with a worse I/R injury after liver transplantationS Weiss, K Kotsch, M Francuski, et al.
Psycho-Oncology|March 16, 2013
Co-morbid mental health conditions in cancer patients at working age--prevalence, risk profiles, and care uptakeS Singer, C Szalai, S Briest, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 14, 2011
Managing chronic myeloid leukemia: a coordinated team care perspectiveStacie Holloway, Katharine Lord, Beverly Bethelmie-Bryan, et al.
Pageof 35